You have access
Follow-up Results of HCV GT2 Patients After Sofosbuvir/Ribavirin Therapy: Careful Attention to Occurrence of HCC
TOMOHIRO KANEKO, TATSUO KANDA, KAZUSHIGE NIREI, NAOKI MATSUMOTO, MOTOMI YAMAZAKI, TOSHIKATSU SHIBATA, AKINORI TAMURA, MASAHIRO OGAWA, NORIKO NAKAJIMA, SHUNICHI MATSUOKA, KAZUMICHI KURODA, TOMOE KOMORIYA, TATSUO YAMAMOTO, TADATOSHI TAKAYAMA and MITSUHIKO MORIYAMA
Anticancer Research July 2019, 39 (7) 3855-3862; DOI: https://doi.org/10.21873/anticanres.13535